DANIEL MUSHER to Vaccines, Conjugate
This is a "connection" page, showing publications DANIEL MUSHER has written about Vaccines, Conjugate.
Connection Strength
1.345
-
Why the recent ACIP recommendations regarding conjugate pneumococcal vaccine in adults may be irrelevant. Hum Vaccin Immunother. 2016; 12(2):331-5.
Score: 0.508
-
The CAPITA study of protein-conjugate pneumococcal vaccine and its implications for use in adults in developed countries. Hum Vaccin Immunother. 2014; 10(5):1331-3.
Score: 0.452
-
The Ongoing Genetic Adaptation of Streptococcus pneumoniae. J Clin Microbiol. 2017 03; 55(3):681-685.
Score: 0.136
-
How effective is vaccination in preventing pneumococcal disease? Infect Dis Clin North Am. 2013 Mar; 27(1):229-41.
Score: 0.104
-
The potential role for protein-conjugate pneumococcal vaccine in adults: what is the supporting evidence? Clin Infect Dis. 2011 Mar 01; 52(5):633-40.
Score: 0.091
-
IgG responses to protein-conjugated pneumococcal capsular polysaccharides in persons who are genetically incapable of responding to unconjugated polysaccharides. Clin Infect Dis. 1998 Dec; 27(6):1487-90.
Score: 0.039
-
Effect of human immunodeficiency virus type 1 infection on the antibody response to a glycoprotein conjugate pneumococcal vaccine: results from a randomized trial. J Infect Dis. 1996 Jan; 173(1):83-90.
Score: 0.008
-
Pneumococcal virulence factors and host immune responses to them. Eur J Clin Microbiol Infect Dis. 1995 Jun; 14(6):479-90.
Score: 0.008